Get started
Author

Ehsan Ghorani

Observed names: E Ghorani, E. Ghorani, Eshan Ghorani, Ghorani, E, Ghorani, E., Ghorani, Ehsan
Observed institutions: Emory University, Imperial College Healthcare NHS Trust, University of Cambridge, West Suffolk NHS Foundation Trust, Cancer Research UK, Hammersmith Hospital, Charing Cross Hospital, Cambridge University Hospitals NHS Foundation Trust, MRC Clinical Trials Unit at UCL, Whipps Cross University Hospital, Wellcome/MRC Institute of Metabolic Science, West Suffolk Hospital, Addenbrooke's Hospital, University College London, Imperial College London, Wellcome Trust, Medical Research Council
ORCID: 0000-0001-5373-5762
Observed ORCID: 0000-0001-5373-5762
OpenAlex ID: A5017654709
Neoantigen-directed immune escape in lung cancer evolution
2019 · Rachel Rosenthal, Elizabeth Larose Cadieux, et al. · Nature · 974
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
2018 · Frederick Arce Vargas, Andrew J.S. Furness, et al. · Cancer Cell · 617
PDF
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
2018 · Matthew A. Lakins, Ehsan Ghorani, et al. · Nature Communications · 601
PDF
Pan-cancer deconvolution of tumour composition using DNA methylation
2018 · Ankur Chakravarthy, Andrew Furness, et al. · Nature Communications · 333
PDF
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
2021 · Lewis Au, Emine Hatipoglu, et al. · Cancer Cell · 271
PDF
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
2019 · Evelyn Menares, Felipe Gálvez-Cancino, et al. · Nature Communications · 256
PDF
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells
2020 · Anna Śledzińska, Maria Vila de Mucha, et al. · Immunity · 233
PDF
Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia
2017 · Ehsan Ghorani, Baljeet Kaur, et al. · The Lancet · 233
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
2020 · Isabelle Solomon, Maria Amann, et al. · Nature Cancer · 221
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
2019 · Kroopa Joshi, Marc Robert de Massy, et al. · Nature Medicine · 217
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
2017 · E. Ghorani, R. Rosenthal, et al. · Annals of Oncology · 143
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
2023 · Ehsan Ghorani, Charles Swanton, et al. · Immunity · 118
PDF
Intraplacental choriocarcinoma: Systematic review and management guidance
2016 · L. Jiao, E. Ghorani, et al. · Gynecologic Oncology · 107
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
2020 · Ehsan Ghorani, James L. Reading, et al. · Nature Cancer · 96
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study
2021 · Antonio Braga, Gabriela Paiva, et al. · The Lancet Oncology · 78
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
2020 · Nouf Alrasheed, Lydia Lee, et al. · Clinical Cancer Research · 74
Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)–European Society of Gynaecologic Oncology (ESGO)–Gynecologic Cancer InterGroup (GCIG)–International Society for the Study of Trophoblastic Diseases (ISSTD)
2025 · Christianne Lok, Nienke van Trommel, et al. · Journal of Clinical Oncology · 67
Using DNA sequencing data to quantify T cell fraction and therapy response
2021 · Robert Bentham, Kevin Litchfield, et al. · Nature · 67
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients
2019 · Kirsty Balachandran, Abdulazeez Salawu, et al. · Gynecologic Oncology · 66
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
2018 · Yien Ning Sophia Wong, Kroopa Joshi, et al. · The Journal of Experimental Medicine · 58
Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience
2015 · Ehsan Ghorani, Han Hsi Wong, et al. · Oncology · 57
Cell communication with the neural plate is required for induction of neural markers by BMP inhibition: evidence for homeogenetic induction and implications for Xenopus animal cap and chick explant assays
2009 · Claudia Linker, Irene De Almeida, et al. · Developmental Biology · 52
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
2023 · Annapaola Mariniello, Tahseen H. Nasti, et al. · Clinical Cancer Research · 49
PDF
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
2023 · Inge O. Baas, Anneke M. Westermann, et al. · Gynecologic and Obstetric Investigation · 40
Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights
2011 · Bella Patel, Aditi Dey, et al. · Molecular Therapy · 30
Works count: 109
Citation count: 5,297
H-index: 26
I10-index: 34
Year
Topic
Type